Yahoo Finance • 5 days ago
* Soligenix (NASDAQ:SNGX [https://seekingalpha.com/symbol/SNGX]) filed to sell 2.91M shares of common stock, 2.91M warrants. * Filing [https://seekingalpha.com/filing/10436085] MORE ON SOLIGENIX * Seeking Alpha’s Quant Rating on... Full story
Yahoo Finance • last month
Get a pulse on the US markets on Monday by checking out the most active stocks in today's session. Discover the stocks that are leading the way in terms of trading volume and market activity. [mostactive] TOP MOST ACTIVE STOCKS TICKE... Full story
Yahoo Finance • last month
(RTTNews) - Soligenix (SNGX) announced that the Office of Orphan Products Development of FDA has granted orphan drug designation to dusquetide, the active ingredient in SGX945, for treatment of Behçet's Disease following review of recent P... Full story
Yahoo Finance • 2 months ago
AUSTIN, Texas, Aug. 08, 2025 (GLOBE NEWSWIRE) -- via IBN – NetworkNewsAudio announces the Audio Press Release (APR) titled “Late-Stage Pipeline Wins Boost Investor Confidence in High-Growth Therapeutic Areas,” featuring Soligenix Inc. (N... Full story
Yahoo Finance • 2 months ago
NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — Soligenix Inc. (NASDAQ: SNGX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 70+ brands within the Dynamic Brand Portfolio@IBN (In... Full story
Yahoo Finance • 2 months ago
Unusual volume stocks are being observed in Monday's session. [unusualvolume] TOP UNUSUAL VOLUME STOCKS TICKER CHANGE COMMENT PBM [https://www.chartmill.com/stock/quote/PBM/profile] 76.28% PSYENCE BIOMEDICAL LTD (NASDAQ:P... Full story
Yahoo Finance • 2 months ago
NEW YORK (AP) — prices for the Nasdaq composite, NYSE and NYSE American listed most active stocks. Nasdaq most active stocks: Stock Name Volume High Low Last Change Oriental Rise Holdings Ltd. 97,958,700 0.1452 0.1206 0.1264 +0.0166 Open... Full story
Yahoo Finance • 2 months ago
NetworkNewsWire Editorial Coverage NEW YORK, Aug. 4, 2025 /CNW/ -- As America's population ages, chronic and rare diseases are emerging as a pressing healthcare challenge — one that disproportionately affects older adults. With more than... Full story
Yahoo Finance • 2 months ago
PRINCETON, N.J. - Soligenix, Inc. (NASDAQ:SNGX) announced Thursday that its Phase 2a proof of concept study evaluating SGX945 (dusquetide) in the treatment of Behçet’s Disease has achieved its objective of demonstrating biological efficacy... Full story
Yahoo Finance • 4 months ago
PRINCETON, N.J., June 06, 2025 (GLOBE NEWSWIRE) -- via IBN – Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases wher... Full story
Yahoo Finance • 6 months ago
AUSTIN, Texas, March 25, 2025 (GLOBE NEWSWIRE) -- via IBN – Soligenix Inc. (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases with an unmet medical need, has s... Full story
Yahoo Finance • 3 years ago
NEW YORK, Oct. 24, 2022 (GLOBE NEWSWIRE) -- FMW Media's New to The Street, a nationally syndicated TV show, announces episode #399 airing tonight, Monday, October 24, 2022, at 10:30 PM PT on the Fox Business Network. New to The Street’s... Full story
Yahoo Finance • 3 years ago
MIAMI, Aug. 16, 2022 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth Companies and Markets announces the Schedule of... Full story
Yahoo Finance • 3 years ago
FLORHAM PARK, N.J., June 03, 2022 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”), a clinical-stage biotechnology company developing placental-derived off-the-shelf allogeneic cell therapies, today announced the appoint... Full story